At our clinic, we offer Tirzepatide for weight loss solutions.

Tirzepatide stands out as the first combination of two classes of medications - a glucagon-like peptide-1 (GLP-1) receptor agonist and a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. This distinctive dual action identifies Tirzepatide as a dual GLP-1/GIP receptor agonist.

Tirzepatide leverages the effects of incretin hormones, specifically GLP-1 and GIP, which are released after meals. By mimicking these hormones, Tirzepatide prompts the pancreas to release insulin post-meal and signals the liver to reduce glucose production.

These effects lead to: Feeling more full, slowing down digestion, lowering blood sugar levels, decreasing appetite, and aiding in weight loss.

Tirzepatideis is conveniently administered once weekly via subcutaneous injection, offering a manageable dosing schedule for individuals seeking effective weight loss solutions.